SYM 1 Biomarkers for the Diagnosis of Cardiovascular Diseases
SYM 2 Diagnostic Challenges in Liver Disease
YR 1 Clinical Chemistry 2010 and Beyond: Opportunities and Challenges for the Next Decade
SYM 3 Tumor Markers in Cancer
IFCC 1 IFCC EMD/CPD Joint Symposium: ELearning and Distance Education in Clinical Chemistry and Laboratory Medicine
SYM 4 Kidney Diseasy – Acute and Chronic
DGKL 1 Role of Non-Medical Scientists in the Medical Laboratory (DGKL)
WS 1 Reporting HBA1C for Monitoring and Diagnosis: The Devils's in the Detail
SYM 5 From Bench to Bedside in Autoimmunity
SYM 6 Diabetes
WS 2 Emerging Infections at AFCB Countries
EFCC 1 How to Assess the Clinical Effectiveness of Laboratory
DGKL 2 Laboratory Medicine – Quo vadis? Conditions, Structure and Developmental Trends in Europe
INT 2 Pitfalls in the Hemostasiologic Diagnostics: Clinical Cases
SYM 7 Pharmacogenetics and Pharmagocenomics
YR 2 Infectious Diseases
WS 3 Oxidative Stress in Diabetes Mellitus
SYM 8 Infectious Diseases
IFCC 2 Biobanking and Laboratory Medicine: Two Resources for Modern Health Care
SYM 9 Haematology and Anaemia
WS 4 Update on Cardiac Troponin – Clinical and Laboratory Issues
SYM 10 Diagnostic Use and Value of Function Test in Endocrinology
SYM 11 Point of Care Testing – Practical Aspects
WS 5 Lessons from the Asian-Pacific Multicenter Reference Interval Study
EFCC 2 Accreditation Should Be Focused on More Than Well Organized Examinations With the Laboratory
DGKL 4 Quality Management according to the German Rilibaek: An International Perspective
WS 6 The 2009 Influenza Pandemic – Lessons Learned
SYM 12 Biomarkers in Acute and Chronic Brain Diseases
YR 3 Developments in Clinical Laboratory Practice
WS 7 Clinical Pharmacogenetics
SYM 13 Prenatal and Neonatal Screening
IFCC 3 Standardization in Molecular Diagnostics
SYM 14 Allergy Diagnostics
DGKL 5 Development of a Transcripting, Proteomic and Metabolomic Database for Human Blood Cells
WS 8 Molecular Diagnosis of Infection
SYM 15 New Developments in Haemostasiology
SYM 16 Contribution of Laboratory Medicine in Leukaemia
WS 9 What Papers Will Be Preferred in the Future Related to Laboratory Medicine? Editors Point of View
EFCC 3 A Scientific Approach to the Post-Analytical Phase
DGKL 6 Research Funding by the Foundation of Pathobiochemistry and Molecular Diagnostics of the DGKL – 10 Years on
INT 1 Challenges at the Clinical Interfaces
SYM 17 New Strategies in Molecular Diagnostic
SYM 18 Standardization and Quality Control Issues in Emerging and Developing Countries
WS 10 Standardisation of Complex Analyte Measurements: The Clinbiotrace Project
SYM 19 Current Challenges in the Pediatric Laboratory
EFCC 4 Standardization of the Pre-Analytical Phase for Markers
SYM 20 Vitamin D: Myth or Magic
IFCC-WASPaLM WS Chronic Kidney Disease – Developing a National Testing Program
WS 11 Biomarkers of Acute and Neurodegenerative Brain Damages
SYM 21 New Technologies in Clinical Application
SYM 22 Intertwining Emergency Medicine and Laboratory Medicine
WS 12 Joint Session with IAT DMCT Trends in Therapeutic Drug Monitoring: Personalized Immunosuppression
IFCC 4 Traceability, Standardisation, Harmonisation: Concepts and Implementation
WS 13 Vitamin Deficiency in Elderly People: Diagnosis, Prevention and Effect on Age-Related Diseases
WS 14 Novel Insights in Iron Metabolism: Implications for Diagnostic Medicine
Copyright © by Walter de Gruyter · Berlin · New York
